Results 91 to 100 of about 6,465,161 (268)

Progression-free survival among patients categorized into 4 groups according to radiotherapy dose and clinical target volume (CTV) margin.

, 2018
Progression-free survival among patients categorized into 4 groups according to radiotherapy dose and clinical target volume (CTV) margin.
Seo Hee Choi (2609779), Chang-Ok Suh (2609776), Sang Kyum Kim (475627), Kyoo-Ho Shin (3578543), Seung Hyun Kim (354159), Hong In Yoon (748799)   +5 more
core   +1 more source

Comparing the paths of Hedgehog release in artificial and natural settings

FEBS Letters, EarlyView.
Hh morphogens require solubilization factors to overcome their tight association with the plasma membrane and signal to distant cells, but the precise functions of these factors are controversial. Here, we use published in vivo observations as the most relevant evidence to test their suggested functions and discuss contradictions and gaps between in ...
Janna Puschmann, Kay Grobe
wiley   +1 more source

Isatuximab, pomalidomide and dexamethasone in the treatment of relapsed/refractory multiple myeloma in real clinical practice [PDF]

Терапевтический архив
Aim. To evaluate the efficacy and tolerability of the combination of isatuximab, pomalidomide, dexamethasone (IsaPd) in the treatment of relapsed refractory multiple myeloma (RRMM) in a real clinical practice. Materials and methods.
Vadim V. Ptushkin, Yulia В. Kochkareva, Ekaterina А. Sukhova, Eugene A. Nikitin   +3 more
doaj   +1 more source

Univariate analysis of progression free survival and overall survival.

, 2016
Univariate analysis of progression free survival and overall survival.
Su Woon Kim (2212930), Balram Chowbay (110465), Ravindran Kanesvaran (780162), Chong Hee Lim (294673), Tina Koh (2212933), Swee Peng Yap (2212924), Quan Sing Ng (780165), Lynette Oon (2212891), Kiat Hon Lim (593520), Chian Min Loo (2212918), Wan Teck Lim (2212903), Anantham Devanand (2212906), Anne Ann Ling Hsu (2212927), Heng Nung Koong (2212936), Cindy Lim (2212915), Daniel Shao Weng Tan (2212921), Mei Kim Ang (381290), Eng Huat Tan (2212939), Amit Jain (2183937), Angela Takano (2212900), Wu Meng Tan (2212909), Eugene MingJin Gan (2212912), Kian Sing Chan (2212894), Chee Keong Toh (780164), Kam Weng Fong (2212942), David Zhihao Ng (2212897)   +25 more
core   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

Molecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti   +11 more
wiley   +1 more source

Overall survival and progression-free survival.

, 2018
The overall survival (OS) rate (dotted line) and progression-free survival (PFS) rate (dashed line) of HCC patients with normal liver volume 3. The patient number was 22. The 1-year progression-free survival and overall survival rates were 40.4% and 81.1%
Shih-Chiang Huang (2522638), Kun-Ming Chan (53874), Shi-Ming Lin (44642), Joseph Tung-Chieh Chang (442849), Jau-Min Lien (5738348), Nai-Jen Liu (5738351), Po-Jui Chen (2223667), Chen-Chun Lin (586445), Wan-Yu Chen (727246), Ngan-Ming Tsang (144670), Wei-Ting Chen (167673), Jeng-Hwei Tseng (5738345), Sheng-Ping Hung (755051), Bing-Shen Huang (791887), Ji-Hong Hong (282811), Ching-Hsin Lee (3207852)   +15 more
core   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Multi-institutional validation of a radiomics signature for identification of postoperative progression of soft tissue sarcoma

Cancer Imaging
Background To develop a magnetic resonance imaging (MRI)-based radiomics signature for evaluating the risk of soft tissue sarcoma (STS) disease progression.
Yuan Yu, Hongwei Guo, Meng Zhang, Feng Hou, Shifeng Yang, Chencui Huang, Lisha Duan, Hexiang Wang   +7 more
doaj   +1 more source

Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

Frontiers in Endocrinology
IntroductionPeptide receptor radionuclide therapy (PRRT) is a treatment option for well-differentiated, somatostatin receptor positive, unresectable or/and metastatic neuroendocrine tumors (NETs).
Vladimir Vukomanovic, Vladimir Vukomanovic, Katarina Vuleta Nedic, Katarina Vuleta Nedic, Marija Zivkovic Radojevic, Marija Zivkovic Radojevic, Aleksandar Dagovic, Aleksandar Dagovic, Neda Milosavljevic, Neda Milosavljevic, Marina Markovic, Marina Markovic, Vladimir Ignjatovic, Vladimir Ignjatovic, Ivana Simic Vukomanovic, Ivana Simic Vukomanovic, Svetlana Djukic, Svetlana Djukic, Marijana Sreckovic, Milena Backovic, Marko Vuleta, Aleksandar Djukic, Aleksandar Djukic, Verica Vukicevic, Vesna Ignjatovic, Vesna Ignjatovic   +25 more
doaj   +1 more source

Kaplan-Meier curve of overall survival and progression-free survival.

, 2016
Kaplan-Meier curve of overall survival and progression-free survival.
Marcelo Bonomi (3216519), Thomas W. Lycan (3216501), Zanetta S. Lamar (3216510), Michael D. Chan (3216522), Antonius A. Miller (3216507), Jimmy Ruiz (3216516), Timothy S. Pardee (143611), Scott Isom (3216513), Angela Alistar (3216504), William J. Petty (3216498)   +9 more
core   +1 more source